Business Description
ACI Formulations Ltd
ISIN : BD0480ACIFL4
Description
ACI Formulations Ltd is an agricultural chemicals manufacturer. The principal activities of the company are manufacturing and marketing a number of agrochemical and consumer products. The company has structured its operations into the following business segments - Crop Care and Public Health segment, which manufactures and sell crop care and public health products; Mosquito Coil segment is engaged in the manufacturing and selling of mosquito coil products; the Aerosol segment is engaged in the manufacturing and selling aerosol and air freshener products; and Paint segment which manufactures and sells paint products. It derives key revenue from the Crop Care and Public Health segment.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 1 | |||||
| Debt-to-EBITDA | 5.89 | |||||
| Interest Coverage | 2.7 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 2.4 | |||||
| Beneish M-Score | -1.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.6 | |||||
| 3-Year EBITDA Growth Rate | 1.1 | |||||
| 3-Year EPS without NRI Growth Rate | 23.3 | |||||
| 3-Year Book Growth Rate | 8.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.46 | |||||
| 9-Day RSI | 43.13 | |||||
| 14-Day RSI | 46.24 | |||||
| 6-1 Month Momentum % | 2 | |||||
| 12-1 Month Momentum % | -6.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.22 | |||||
| Quick Ratio | 0.74 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 184.69 | |||||
| Days Sales Outstanding | 103.61 | |||||
| Days Payable | 17.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.59 | |||||
| Dividend Payout Ratio | 0.48 | |||||
| 3-Year Dividend Growth Rate | -3.4 | |||||
| Forward Dividend Yield % | 1.59 | |||||
| 5-Year Yield-on-Cost % | 2.51 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 27.01 | |||||
| Operating Margin % | 10.74 | |||||
| Net Margin % | 5.15 | |||||
| ROE % | 7.85 | |||||
| ROA % | 3.58 | |||||
| ROIC % | 6.34 | |||||
| ROC (Joel Greenblatt) % | 9.89 | |||||
| ROCE % | 16.12 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 29.82 | |||||
| PE Ratio without NRI | 29.92 | |||||
| Shiller PE Ratio | 30.94 | |||||
| PEG Ratio | 24.93 | |||||
| PS Ratio | 1.53 | |||||
| PB Ratio | 2.29 | |||||
| Price-to-Tangible-Book | 2.28 | |||||
| EV-to-EBIT | 19.94 | |||||
| EV-to-EBITDA | 19.16 | |||||
| EV-to-Revenue | 2.17 | |||||
| EV-to-FCF | -19.66 | |||||
| Price-to-Projected-FCF | 3.08 | |||||
| Price-to-DCF (Earnings Based) | 2.39 | |||||
| Price-to-Peter-Lynch-Fair-Value | 5.58 | |||||
| Price-to-Graham-Number | 1.74 | |||||
| Price-to-Net-Current-Asset-Value | 9.81 | |||||
| Earnings Yield (Greenblatt) % | 5.01 | |||||
| Forward Rate of Return (Yacktman) % | 5.91 |
Balance Sheet Breakdown
Cashflow Statement Breakdown
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
ACI Formulations Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil BDT) | 4,833.775 | ||
| EPS (TTM) (BDT) | 5.27 | ||
| Beta | 0 | ||
| Volatility % | 15.94 | ||
| 14-Day RSI | 46.24 | ||
| 14-Day ATR (BDT) | 3.724819 | ||
| 20-Day SMA (BDT) | 159.355 | ||
| 12-1 Month Momentum % | -6.89 | ||
| 52-Week Range (BDT) | 151.1 - 199.2 | ||
| Shares Outstanding (Mil) | 47.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ACI Formulations Ltd Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
ACI Formulations Ltd Stock Events
| Event | Date | Price(BDT) | ||
|---|---|---|---|---|
| No Event Data | ||||
ACI Formulations Ltd Frequently Asked Questions
What is ACI Formulations Ltd(DHA:ACIFORMULA)'s stock price today?
The current price of DHA:ACIFORMULA is BDT157.20. The 52 week high of DHA:ACIFORMULA is BDT199.20 and 52 week low is BDT151.10.
When is next earnings date of ACI Formulations Ltd(DHA:ACIFORMULA)?
The next earnings date of ACI Formulations Ltd(DHA:ACIFORMULA) is .
Does ACI Formulations Ltd(DHA:ACIFORMULA) pay dividends? If so, how much?
The Dividend Yield %  of ACI Formulations Ltd(DHA:ACIFORMULA) is 1.59% (As of Today), Highest Dividend Payout Ratio of ACI Formulations Ltd(DHA:ACIFORMULA) was 1.7. The lowest was 0.34. And the median was 0.58. The  Forward Dividend Yield % of ACI Formulations Ltd(DHA:ACIFORMULA) is 1.59%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
